Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOBI for Chronic obstructive pulmonary disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where TOBI was used for Chronic obstructive pulmonary disease.

Most Reported Side Effects for TOBI

Side Effect Reports % Deaths Hosp.
Death 89 34.2% 89 7
Dyspnoea 29 11.2% 4 19
Cystic fibrosis 25 9.6% 6 18
Cough 24 9.2% 2 14
Condition aggravated 23 8.9% 1 20
Pneumonia 20 7.7% 3 18
Pseudomonas infection 19 7.3% 3 12
Malaise 12 4.6% 1 7
Drug administered to patient of inappropriate age 11 4.2% 1 3
Chronic obstructive pulmonary disease 10 3.9% 4 7
Pyrexia 10 3.9% 1 7
Chest discomfort 9 3.5% 0 5
Productive cough 9 3.5% 1 6
Bronchiectasis 8 3.1% 2 6
Haemoptysis 8 3.1% 1 5

Other Indications for TOBI

Cystic fibrosis (97) Bronchiectasis (52) Pseudomonas infection (21) Off label use (12) Pneumonia pseudomonal (12) Bronchitis (5)

Other Drugs Used for Chronic obstructive pulmonary disease

TIOTROPIUM (20,175) FLUTICASONE\SALMETEROL (8,896) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (8,730) ALBUTEROL (8,572) BUDESONIDE\FORMOTEROL (6,539) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (4,580) UMECLIDINIUM\VILANTEROL TRIFENATATE (4,512) DUPILUMAB (3,526) ALBUTEROL\IPRATROPIUM (3,289) ACLIDINIUM (2,321)

Related Pages

TOBI Full Profile All Chronic obstructive pulmonary disease Drugs TOBI Demographics TOBI Timeline